APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 1.071
EU - Europa 1.044
AS - Asia 190
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.312
Nazione #
US - Stati Uniti d'America 1.068
GB - Regno Unito 355
IE - Irlanda 198
CN - Cina 130
UA - Ucraina 98
SE - Svezia 96
IT - Italia 73
RU - Federazione Russa 69
DE - Germania 66
FR - Francia 46
SG - Singapore 40
FI - Finlandia 24
VN - Vietnam 8
BE - Belgio 5
AU - Australia 3
CZ - Repubblica Ceca 3
IN - India 3
NL - Olanda 3
CA - Canada 2
EC - Ecuador 2
IR - Iran 2
PT - Portogallo 2
SM - San Marino 2
TR - Turchia 2
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
Totale 2.312
Città #
Southend 335
Dublin 197
Fairfield 160
Chandler 111
Woodbridge 102
Jacksonville 79
Ashburn 71
Wilmington 69
Ann Arbor 61
Houston 53
Seattle 49
Cambridge 45
Nanjing 32
Princeton 32
Singapore 32
Beijing 31
Siena 20
Boardman 13
New York 12
Nanchang 10
Shanghai 10
Helsinki 9
Dong Ket 8
San Mateo 7
Hebei 6
San Diego 6
Tianjin 6
Brussels 5
Shenyang 5
Cagliari 4
Florence 4
London 4
Moscow 4
Norwalk 4
Poggibonsi 4
Taizhou 4
Zhengzhou 4
Atlanta 3
Brno 3
Changsha 3
Dallas 3
Hangzhou 3
San Francisco 3
Arezzo 2
Arienzo 2
Bethesda 2
Boston 2
Brescia 2
Campi Bisenzio 2
Castiglion Fiorentino 2
Düsseldorf 2
Falkenstein 2
Guangzhou 2
Haikou 2
Hyderabad 2
Izmir 2
Jiaxing 2
Kansas City 2
Kunming 2
Leawood 2
Lisbon 2
Menlo Park 2
Munich 2
Newark 2
Ningbo 2
Paliano 2
Pisa 2
Quito 2
Redwood City 2
Sacramento 2
Serravalle 2
Vienna 2
Adelaide 1
Akron 1
Almaty 1
Almere Stad 1
Canberra 1
Catania 1
Cheboksary 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Dearborn 1
Fremont 1
Fuzhou 1
Hamilton 1
Jinan 1
Kilburn 1
Lanzhou 1
Malang 1
Markham 1
Melbourne 1
Mexico City 1
Milan 1
Málaga 1
Paderno Dugnano 1
Padova 1
Phoenix 1
Pune 1
Totale 1.712
Nome #
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 199
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 197
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 155
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 149
Peptide vaccines for hematological malignancies: a missed promise? 140
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 136
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 133
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 131
null 130
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 128
FLT3 inhibitors in the management of acute myeloid leukemia 124
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 120
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 116
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 113
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 105
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 98
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 76
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 63
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 27
Totale 2.340
Categoria #
all - tutte 7.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 0 0 0 0 37 47 36 76 55 43 11 28
2020/2021324 15 38 11 32 25 27 18 42 32 22 23 39
2021/2022229 24 16 12 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/2025122 6 19 62 19 16 0 0 0 0 0 0 0
Totale 2.340